CME webinar: Screening and Assessment for Suicide Prevention
Sep. 2022Education/Webinars
"September is National Suicide Awareness Month, and you are invited to watch a timely recorded webinar on the topic. Andrei Nemoianu, MD, Regional Medical Director, Community Care Behavioral Health Organization, discusses:
*This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
*Provider is responsible for verifying CME eligibility."
- How to define suicide screening and identify how often it should be used.
- Suicide assessment and when it should be done.
- How to gain greater familiarity with formulating a suicide risk assessment.
- Three suicide screening tools.
- How to locate resources to help develop a policy around suicide screening and assessment.
*This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
*Provider is responsible for verifying CME eligibility."
Recent Announcements
Medicaid Renewal
Starting in 2027, some Medicaid recipients (ages 19–-64) will have new requirements to keep their coverage.Aug. 2026Important Notices
Provider Directory Updates and Required Attestation
As you know, UPMC Health Plan requires all providers to verify their provider directory information at least every 90 days (quarterly).Aug. 2026Important Notices
Voluntary nationwide recall: Tyenne (Fresenius – August 2026)
Fresenius Kabi is recalling one lot, lot 16UI07, of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL) 20 mL vials. Tyenne is used for the treatment of certain arthritis conditions.Aug. 2026Pharmacy Updates